# Janus Living, Inc.: financial statements, quarterly

JAN · NYSE · CIK 2100805 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jan.md) · [Financials](/companies/jan/financials.md) · [Filings](/companies/jan/filings.md) · [Insiders](/companies/jan/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jan/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [149](/filings/0001628280-26-031293.md) | [149](/filings/0001628280-26-053387.md) | [200](/filings/0001628280-26-031293.md) | [216](/filings/0001628280-26-053387.md) |
| Income tax | $m | [2.6](/filings/0001628280-26-031293.md) | [2.1](/filings/0001628280-26-053387.md) | [1.1](/filings/0001628280-26-031293.md) | [(1.7)](/filings/0001628280-26-053387.md) |
| Net income | $m | [(2.1)](/filings/0001628280-26-031293.md) | [(2.6)](/filings/0001628280-26-053387.md) | [27.9](/filings/0001628280-26-031293.md) | [10.7](/filings/0001628280-26-053387.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001628280-26-031293.md) | [0.00](/filings/0001628280-26-053387.md) | [(0.05)](/filings/0001628280-26-031293.md) | [0.05](/filings/0001628280-26-053387.md) |
| Basic EPS | $ per share | [0.00](/filings/0001628280-26-031293.md) | [0.00](/filings/0001628280-26-053387.md) | [(0.05)](/filings/0001628280-26-031293.md) | [0.05](/filings/0001628280-26-053387.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.8](/filings/0001628280-26-053387.md) | [21.2](/filings/0001628280-26-031293.md) | [22.6](/filings/0001628280-26-053387.md) | [19.7](/filings/0001628280-26-053387.md) | [949](/filings/0001628280-26-031293.md) | [1,558](/filings/0001628280-26-053387.md) |
| Total assets | $m | not reported | not reported | not reported | [2,342](/filings/0001628280-26-053387.md) | [4,024](/filings/0001628280-26-031293.md) | [4,710](/filings/0001628280-26-053387.md) |
| Total liabilities | $m | not reported | not reported | not reported | [1,060](/filings/0001628280-26-053387.md) | [978](/filings/0001628280-26-031293.md) | [1,005](/filings/0001628280-26-053387.md) |
| Shareholders' equity | $m | [1,309](/filings/0001628280-26-053387.md) | [1,304](/filings/0001628280-26-053387.md) | [1,289](/filings/0001628280-26-053387.md) | [1,282](/filings/0001628280-26-053387.md) | [2,165](/filings/0001628280-26-031293.md) | [2,739](/filings/0001628280-26-053387.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [20.8](/filings/0001628280-26-031293.md) | [49.5 d](/filings/0001628280-26-053387.md) | [33.3](/filings/0001628280-26-031293.md) | [79.6 d](/filings/0001628280-26-053387.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001628280-26-031293.md) | [0.0](/filings/0001628280-26-053387.md) | [263](/filings/0001628280-26-031293.md) | [271](/filings/0001628280-26-053387.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.